Closed to accrual: MYC2 step #1
Published:Category: Trials
The MYC2 trial (SWOG S1803) - A Phase III Study of Daratumumab/rHuPH20 (NSC- 810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients with Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study) - has closed Step #1 registration of new study participants having successfully reach the target accrual goal (n=1420 for Screening Step). Step #2 and Step #3 remain open.
Read MoreGI committee recognizes new investigators
Published:Category: Group updates
The CCTG Gastro-Intestinal Disease Site Committee would like to recognize Dr Vincent Barrette and Dr Anthony Lott for their accrual contributions to the CRC10 study as new investigators.
Read MoreCRA Lunch and Learn training program
Published:Category: Group updates
CCTG will be holding the next CRA Lunch and Learn on Wednesday January 22nd, 2025, at 12 pm ET. Session 2 will cover the topic of CCTG Website Navigation and Communications.
Read MorePublications: BRC5 and PAC3
Published:Category: Publications
BRC5 - Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non–small cell lung cancer: A post hoc analysis. Also PAC3- Identification and validation the predictive biomarkers based on risk-adjusted control chart in gemcitabine with or without erlotinib for pancreatic cancer therapy. Read More
Trial closure: MA41
Published:Category: Trials
MA41 trial investigating a de-Escalation of adjuvant chemotherapy in HER-2 positive, estrogen receptor-negative, node-negative, early breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy and dual HER-2 blockade (DECRESCENDO) trial has now permanently closed.
Read MoreClosed to Accrual: MAC22
Published:Category: Trials
The MAC22 trial (ECOG-ACRIN EA1151) tomosynthesis mammographic imaging screening trial (TMIST) has closed to accrual having reached the goal of 108,508 participants enrolled across North America. Congratulations to our Canadian sites who contributed almost 13 percent of the total accrual for this intergroup trial.
Read MorePatient Cancer Research Priorities
Published:Category: Group updates
In April 2024, at the CCTG Spring Meeting of Participants, the CCTG Patient Representative Committee members participated in a facilitated session designed to identify the research topics that Committee members view as being most important to cancer patients and caregivers. The outcome of the workshop resulted in the identification by the CCTG reps of six Cancer Research Priorities.
Read MoreCCTG 2024 Holiday Closures
Published:Category: Group updates
CCTG central office holiday season hours of operation with information on the Tissue Bank notice on shipment of specimens and kit supply. Happy Holiday to everyone in the CCTG network. Read More